Mild renal dysfunction is a risk factor for a decrease in bone mineral density and vertebral fractures in Japanese postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages 4635-4642

  Kaji, Hiroshi ^a,b   Yamauchi, Mika ^c   Yamaguchi, Toru ^c   Shigematsu, Takashi ^d   Sugimoto, Toshitsugu ^c  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ESTRADIOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BONE DENSITY; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CORRELATION ANALYSIS; CREATININE CLEARANCE; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RADIUS; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; THORACIC SPINE; VERTEBRA FRACTURE;

EID: 77957779216     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0099     Document Type: Article

References (44)

1. Lindberg JS, Moe SM 1999 Osteoporosis in end-state renal disease. Semin Nephrol 19:115-122
2. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C 2000 Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396-399
3. Lin J, Knight EL, Hogan ML, Singh AK 2003 A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 14:2573-2580
4. Nickolas TL, Leonard MB, Shane E 2008 Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721-731
5. Nickolas TL, McMahon DJ, Shane E 2006 Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17:3223-3232
6. Coco M, Rush H 2000 Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115-1121
7. Stein MS, Packham DK, Ebeling PR, Wark JD, Becker GJ 1996 Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 28:515-522
8. Kaji H, Suzuki M, Yano S, Sugimoto T, Chihara K, Hattori S, Sekita K 2002 Risk factors for hip fracture in hemodialysis patients. Am J Nephrol 22:325-331
9. Dukas L, Schacht E, Stähelin HB 2005 In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos Int 16:1683-1690
10. Jassal SK, von Muhlen D, Barrett-Connor E 2007 Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo Study. J Bone Miner Res 22:203-210
11. Bacchetta J, Boutroy S, Vilayphiou N, Juillard L, Guebre-Egziabher F, Rognant N, Sornay-Rendu E, Szulc P, Laville M, Delmas PD, Fouque D, Chapurlat R 2010 Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res 25:849-857
12. Kovesdy CP, Kalantar-Zadeh K 2008 Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol 40:427-440
13. Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G 9 December 2009 Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporos Int 10.1007/s00198-009-1142-4
14. Ix JH, Shlipak MG, Wassel CL, Whooley MA 2010 Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant 25:993-997
15. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Rits E, Kronenberg F, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P, the MMKD Study Group 2007 Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the mild to moderate kidney disease (MMKD) study. J Am Soc Nephrol 18:2600-2608
16. Lund RJ, Davies MR, Brown AJ, Hruska KA 2004 Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol 15:359-369
17. Davies MR, Lund RJ, Mathew S, Hruska KA 2005 Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 16:917-928
18. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G 2003 National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137-147
19. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A 2009 Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992
20. Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S 2007 Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 11:156-163 (Pubitemid 47012510)
21. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S 2009 Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 13:621-630
22. Dubois D, Bois ED 1916 A formula to estimate the approximate surface area if height and weight are known. Arch Intern Med 17: 863-871
23. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts Jr JT, Segre GV 1987 Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367
24. Frölich M, Walma ST, Paulson C, Papapoulos SE 1990 Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radio-immunoassay. Ann Clin Biochem 27:69-72
25. Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K 2000 Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 85:1901-1907 (Pubitemid 32269296)
26. Fukase M, Fujita T, Matsumoto T, Ogata E, Iijima T, Takezawa J, Saito K, Ishige H, Fujimoto M 1989 Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic status. Nippon Naibunpi Gakkai Zasshi 65:807-827
27. Smith-Bindman R, Cummings SR, Steiger P, Genant HK 1991 A comparison of morphometric definitions of vertebral fractures. J Bone Miner Res 6:25-34
28. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS 2003 Prevalence of chronic kidney disease and decreased kidney function in the adult U.S. population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1-12
29. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modified of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470
30. Lin J, Knight EL, Hogan ML, Singh AK 2003 A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 14:2573-2580
31. Garg AX, Papaioannou A, Ferko N, Campbell G, Clarke JA, Ray JG 2004 Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int 65:649-653
32. Yendt ER, Cohanim M, Jarzylo S, Jones G, RosenbergG1991 Bone mass is related to creatinine clearance in normal elderly women. J Bone Miner Res 6:1043-1050
33. Yendt ER, Cohanim M, Jarzylo S, Jones G, Rosenberg G 1993 Reduced creatinine clearance in primary osteoporosis in women. J Bone Miner Res 8:1045-1052
34. Klawansky S, Komaroff E, Cavanaugh Jr PF, Mitchell DY, Gordon MJ, Connelly JE, Ross SD 2003 Relationship between age, renal function and bone mineral density in the U.S. population. Osteoporos Int 14:570-576
35. Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR; Osteoporotic Research Group 2007 Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133-139
36. NIH Consensus Development Panel on Osteoporosis Prevention 2001 Osteoporosis prevention, diagnosis, and the therapy. JAMA 285:785-795
37. Hou FF, Ren H, Owen Jr WF, Guo ZJ, Chen PY, Schmidt AM, Miyata T, Zhang X 2004 Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol 15:1889-1896
38. Shiraki M, Kuroda T, Tanaka S, Saito M, Fukunaga M, Nakamura T 2008 Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab 26:93-100
39. Bacchetta J, Boutroy S, Guebre-Egziabher F, Juillard L, Drai J, Pelletier S, Richard M, Charrié A, Carlier MC, Chapurlat R, Laville M, Fouque D 2009 The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. Nephrol Dial Transplant 24:3120-3125
40. Leboff MS, Narweker R, LaCroix A, Wu L, Jackson R, Lee J, Bauer DC, Cauley J, Kooperberg C, Lewis C, Thomas AM, Cummings S 2009 Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 94:1207-1213
41. Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Jüppner H, Wolf M 2005 Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205-2215
42. Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M 2008 Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19:615-623
43. Edwards BJ, Langman CB, Bunta AD, Vicuna M, Favus M 2008 Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int 19:991-999
44. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ 1984 Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74:2136-2143